Arkolith/Insider Trading/CMPI/Form 4

venBio Global Strategic Fund II L.P.

10% OwnerCheckmate Pharmaceuticals, Inc. (CMPI) · full profile →Form 4 · filed May 12, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.7M
Net Open-Market Flow
-$1.7M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 12, 2022Sell(S)125K$10.39$1.3M2.3M
May 11, 2022Sell(S)18K$10.38$184K2.4M
May 10, 2022Sell(S)19K$10.38$194K2.4M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001567619-22-010353) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML